These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12658557)

  • 1. Dorzolamide X apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy.
    Arieta C; Amaral M; Matuda E; Crosta C; de Carvalho Moreira Filho D; José N
    Curr Eye Res; 2002 Oct; 25(4):237-41. PubMed ID: 12658557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
    Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
    Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
    Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised fellow eye comparison of the effectiveness of dorzolamide and apraclonidine on intraocular pressure following phacoemulsification cataract surgery.
    Rainer G; Menapace R; Findl O; Georgopoulos M; Kiss B; Heinze G
    Eye (Lond); 2000 Oct; 14 Pt 5():757-60. PubMed ID: 11116699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group.
    Hartenbaum D; Wilson H; Maloney S; Vacarelli L; Orillac R; Sharpe E
    J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)].
    Lachmann C; Jörg KM; Trinkmann R
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):326-30. PubMed ID: 10048009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neodymium:yttrium-aluminum-garnet capsulotomy and intraocular pressure in pseudophakic patients with glaucoma.
    Barnes EA; Murdoch IE; Subramaniam S; Cahill A; Kehoe B; Behrend M
    Ophthalmology; 2004 Jul; 111(7):1393-7. PubMed ID: 15234143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.
    Cullom RD; Schwartz LW
    Ophthalmic Surg; 1993 Sep; 24(9):623-6. PubMed ID: 7901828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of apraclonidine to prevent delayed IOP elevation after Nd:YAG laser posterior capsulotomy.
    Nesher R; Kolker AE
    Trans Am Ophthalmol Soc; 1990; 88():229-32; discussion 233-6. PubMed ID: 1982748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
    Onal S; Gozum N; Gucukoglu A
    Ophthalmic Surg Lasers Imaging; 2005; 36(6):457-62. PubMed ID: 16355950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
    Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
    Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerability of apraclonidine (ALO 2145, 1%) in the prevention of early ocular hypertonia, after trabeculoretraction using argon laser and posterior capsulotomy using Nd:YAG laser].
    Raspiller A; Berrod JP
    J Fr Ophtalmol; 1992; 15(12):651-6. PubMed ID: 1363731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of topic ocular hipotensive agents after posterior capsulotomy].
    Minello AA; Prata Junior JA; Mello PA
    Arq Bras Oftalmol; 2008; 71(5):706-10. PubMed ID: 19039468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy.
    Yeom HY; Lee JH; Hong YJ; Seong GJ
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):176-81. PubMed ID: 16808678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apraclonidine prevents the acute increase of intraocular pressure in brown eyes with Nd:YAG laser iridectomy].
    Zhao J; Mao J; Liu X
    Zhonghua Yan Ke Za Zhi; 1998 May; 34(3):170-3. PubMed ID: 11877181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.